![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Doggrell Sheila A
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.14, Iss.8, 2005-08, pp. : 1063-1066
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Imatinib mesylate in the treatment of chronic myeloid leukaemia
Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Imatinib: A Review of its Use in Chronic Myeloid Leukaemia
By Moen Marit D. McKeage Kate Plosker Greg L. Siddiqui M. Asif A.
Drugs, Vol. 67, Iss. 2, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)